share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  05/22 13:49

Moomoo AI 已提取核心信息

Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 7,073 shares of common stock on 05/22/2024, as per the latest filing. The shares, valued at approximately $3,168,704, were originally acquired on the same date through an option granted on 06/01/2016. The transaction will be conducted with cash as the nature of payment. No other sales of securities have been reported by Sachs in the past three months.
Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 7,073 shares of common stock on 05/22/2024, as per the latest filing. The shares, valued at approximately $3,168,704, were originally acquired on the same date through an option granted on 06/01/2016. The transaction will be conducted with cash as the nature of payment. No other sales of securities have been reported by Sachs in the past three months.
根据最新文件,Vertex Pharmicals Inc.董事布鲁斯·萨克斯定于2024年5月22日出售7,073股普通股。这些股票价值约3,168,704美元,最初是通过2016年1月6日授予的期权于同日收购的。该交易将以现金作为付款性质进行。在过去的三个月中,萨克斯没有报告其他证券销售情况。
根据最新文件,Vertex Pharmicals Inc.董事布鲁斯·萨克斯定于2024年5月22日出售7,073股普通股。这些股票价值约3,168,704美元,最初是通过2016年1月6日授予的期权于同日收购的。该交易将以现金作为付款性质进行。在过去的三个月中,萨克斯没有报告其他证券销售情况。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息